Abstract: Disclosed are redistribution substrates and semiconductor packages including the same. The semiconductor package comprises a redistribution substrate, a semiconductor chip mounted on the redistribution substrate, and an inductor structure in the redistribution substrate and electrically connected to the semiconductor chip. The inductor structure includes an outer coil pattern including a plurality of vertical parts and a horizontal part that connects the plurality of vertical parts to each other, and an inner coil pattern between the vertical parts and electrically connected to the outer coil pattern. The horizontal part includes a first conductive layer, and a second conductive layer between the first conductive layer and the inner coil pattern. The second conductive layer has a thickness that is less than a thickness of the first conductive layer.

Abstract: The disclosure refers to a method of preventing or treating heart failure in a patient using (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide (INN: Finerenone).

Abstract: The disclosure refers to a method of preventing or treating heart failure in a patient using (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide (INN: Finerenone).

Abstract: Disclosed are redistribution substrates and semiconductor packages including the same. The semiconductor package comprises a redistribution substrate, a semiconductor chip mounted on the redistribution substrate, and an inductor structure in the redistribution substrate and electrically connected to the semiconductor chip. The inductor structure includes an outer coil pattern including a plurality of vertical parts and a horizontal part that connects the plurality of vertical parts to each other, and an inner coil pattern between the vertical parts and electrically connected to the outer coil pattern. The horizontal part includes a first conductive layer, and a second conductive layer between the first conductive layer and the inner coil pattern. The second conductive layer has a thickness that is less than a thickness of the first conductive layer.

Abstract: A lithium-sulfur battery capable of retaining excellent energy density and capacity even when discharged at a fast rate and a method of manufacturing the same are provided. The lithium-sulfur battery has a ratio of an amount of lithium sulfide (Li2S) present at 100% depth of discharge state (DoD 100) of the lithium-sulfur battery discharged at 1.0 C to an amount of lithium sulfide (Li2S) present at DoD 100 of the lithium-sulfur battery discharged at 0.5 C. of 80% or more.

Abstract: The disclosure refers to a method of preventing or treating heart failure in a patient using (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide(INN: Finerenone).

Abstract: The disclosure refers to a method of preventing or treating heart failure in a patient using (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide (INN: Finerenone).

Abstract: A lithium-sulfur battery capable of retaining excellent energy density and capacity even when discharged at a fast rate and a method of manufacturing the same are provided. The lithium-sulfur battery has a ratio of an amount of lithium sulfide (Li2S) present at 100% depth of discharge state (DoD 100) of the lithium-sulfur battery discharged at 1.0 C to an amount of lithium sulfide (Li2S) present at DoD 100 of the lithium-sulfur battery discharged at 0.5 C of 80% or more.

Abstract: Disclosed is a method of predicting cycle life of a secondary battery comprising a carbon-based hybrid negative electrode, including: measuring a lattice d-spacing of a carbon based negative electrode active material of a target carbon-based hybrid negative electrode using an X-ray diffractometer during charging/discharging of a target secondary battery, and plotting a graph of changes in lattice d-spacing value as a function of charge/discharge capacity (X axis); calculating a target slope difference corresponding to a difference in slope value changed with respect to an inflection point of the graph during discharging in the plotted graph; comparing the target slope difference with a reference slope difference; and predicting if the cycle life of the target secondary battery is improved compared to the reference secondary battery from a result of the comparison.

Abstract: A semiconductor device includes a device wafer having a first side and a second side, a bus located on the second side of the device wafer, and a top wafer having a first side and a second side. A plurality of qubits are located on the first side of the device wafer, and a first plurality of bump bonds located on the first side of the top wafer bond the top wafer with the second side of the device wafer.

Abstract: The composition inhibits severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) via competitive binding to SARS-COV-2 spike protein. The composition includes a plurality of sulfated glycosaminoglycans which bind to SARS-COV-2 spike protein, preventing binding to and uptake by host cells. The sulfated glycosaminoglycans, including N-, 2-O, 3-O, or 6-O sulfate groups, or combinations thereof, include heparins and fucoidans, such as those isolated from brown seaweed. The compositions show antiviral activity, with EC50 as low as 0.08 ?M, and low cytotoxicity, making it promising for clinical use. While established SARS-COV-2 treatments such as remdesivir need to be administered intravenously, the compositions discussed herein are advantageously capable to being delivered as a nasal spray, metered dose inhaler, oral delivery, etc.

Abstract: The composition inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via competitive binding to SARS-CoV-2 spike protein. The composition includes a plurality of sulfated glycosaminoglycans which bind to SARS-CoV-2 spike protein, preventing binding to and uptake by host cells. The sulfated glycosaminoglycans, including N-, 2-O, 3-O, or 6-O sulfate groups, or combinations thereof, include heparins and fucoidans, such as those isolated from brown seaweed. The compositions show antiviral activity, with EC50 as low as 0.08 ?M, and low cytotoxicity, making it promising for clinical use. While established SARS-CoV-2 treatments such as remdesivir need to be administered intravenously, the compositions discussed herein are advantageously capable to being delivered as a nasal spray, metered dose inhaler, oral delivery, etc.

Abstract: A lithium-sulfur battery having high energy density and a method for manufacturing the same are provided. The lithium-sulfur battery at depth of discharge (DOD) 15% to DOD 80% includes a compound having three or more characteristic peaks of diffraction angles (2? values) of X-ray diffraction (XRD) patterns selected from 7.1±0.2°, 9.0±0.2°, 9.4±0.2°, 9.6±0.2°, 9.9±0.2°, 10.0±0.2°, 10.4±0.2°, 11.0±0.2°, 11.6±0.2°, 12.1±0.2°, 13.3±0.2°, 14.5±0.2° and 15.0±0.2°.

Abstract: A method of quantitatively analyzing a carbon based hybrid negative electrode including the steps of preparing a secondary battery including a carbon based hybrid negative electrode, where the carbon based hybrid negative electrode comprises a carbon based negative electrode active material and a non-carbon based negative electrode active material, measuring a lattice d-spacing of the carbon based negative electrode active material in the carbon based hybrid negative electrode during charging/discharging of the secondary battery using an X-ray diffractometer and then plotting a graph of a change in lattice d-spacing value as a function of charge/discharge capacity, detecting an inflection point of a slope of the graph during discharging; and then, quantifying capacity contribution of the carbon based negative electrode active material and the non-carbon based negative electrode active material in the total discharge capacity of the secondary battery by the inflection point of the slope of the graph.

Abstract: A lithium-sulfur battery capable of retaining excellent energy density and capacity even when discharged at a fast rate and a method of manufacturing the same are provided. The lithium-sulfur battery has a ratio of an amount of lithium sulfide (Li2S) present at 100% depth of discharge state (DoD 100) of the lithium-sulfur battery discharged at 1.0 C to an amount of lithium sulfide (Li2S) present at DoD 100 of the lithium-sulfur battery discharged at 0.5 C of 80% or more.

Abstract: The present invention relates to a composition, a kit, and a method of providing information for diagnosis, which are capable of diagnosing pancreatic cancer and capable of diagnosing pancreatic cancer by distinguishing it from other pancreatic diseases or other cancer types.

Abstract: Disclosed is a semiconductor package comprising a logic die mounted on an interposer substrate, and a memory stack structure disposed side-by-side with the logic die. The memory stack structure includes a buffer die mounted on the interposer substrate, and a plurality of memory dies stacked on the buffer die. The buffer die has a first surface that faces the interposer substrate and a second surface that faces the plurality of memory dies. The number of data terminals on the second surface is greater the number of connection terminals on the first surface.

Abstract: A foldable device includes: a flexible display configured to display an execution screen of an application; and a controller configured to control the flexible display to display an execution screen of at least one first application on a first surface of the flexible display that is used as a display of the foldable device when the flexible display is folded, and control, in response to the flexible display being unfolded, the flexible display to display the execution screen of the at least one first application and an execution screen of at least one second application related to the at least one first application to be displayed on a second surface of the flexible display that is used as a display of the foldable device when the flexible display is unfolded.

Abstract: Disclosed is a semiconductor package comprising a logic die mounted on an interposer substrate, and a memory stack structure disposed side-by-side with the logic die. The memory stack structure includes a buffer die mounted on the interposer substrate, and a plurality of memory dies stacked on the buffer die. The buffer die has a first surface that faces the interposer substrate and a second surface that faces the plurality of memory dies. The number of data terminals on the second surface is greater the number of connection terminals on the first surface.

Abstract: The composition inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via competitive binding to SARS-CoV-2 spike protein. The composition includes a plurality of sulfated glycosaminoglycans which bind to SARS-CoV-2 spike protein, preventing binding to and uptake by host cells. The sulfated glycosaminoglycans, including N-, 2-O, 3-O, or 6-O sulfate groups, or combinations thereof, include heparins and fucoidans, such as those isolated from brown seaweed. The compositions show antiviral activity, with EC50 as low as 0.08 ?M, and low cytotoxicity, making it promising for clinical use. While established SARS-CoV-2 treatments such as remdesivir need to be administered intravenously, the compositions discussed herein are advantageously capable to being delivered as a nasal spray, metered dose inhaler, oral delivery, etc.